|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.750 EUR | -1.45% |
|
-5.00% | -30.56% |
| 03-25 | Hyloris Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 01-20 | Hyloris Pharmaceuticals Partners With Orion to Commercialize Gastric Acid Treatment | MT |
Analyst Reco.
Search
No results match your criteria
- Stock Market
- Stocks
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Analyst Reco.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition